Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | HRH1 | P35367 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA3 | P07451 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA6 | P23280 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27425378 | 0.84 | ALDH1A1 (0.41) | HTR2AHRH1ALDH1A1TSHR | |
| SCHEMBL27425376 | 0.82 | ALDH1A1 (0.46) | HTR2AHRH1ALDH1A1TSHR | |
| SCHEMBL17692588 | 0.81 | — | — | |
| SCHEMBL10631081 | 0.79 | MAPT (0.33) | HTR2AHRH1MAPT | |
| SCHEMBL8147380 | 0.77 | HTR2A (0.31) | HTR2AHRH1 | |
| SCHEMBL10790532 | 0.76 | ALDH1A1 (0.43) | HTR2AHRH1ALDH1A1TSHRTDP1 | |
| SCHEMBL16350189 | 0.74 | TSHR (0.33) | TSHR | |
| SCHEMBL711528 | 0.72 | GABRR1 (0.33) | — | |
| SCHEMBL23846278 | 0.71 | HTR2A (0.37) | HTR2AHRH1ALDH1A1TSHRTDP1 | |
| SCHEMBL14383723 | 0.71 | HTR2A (0.37) | HTR2AHRH1ALDH1A1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 454 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240287363-A1 | POLYCAPROLACTONE POLYOLS, POLYURETHANES, AND METHODS OF MAKING AND USING THE SAME | INGEVITY UK LTD (GB) | 2024-08-29 | — | — | US | claimed |
| US-10982036-B2 | Polymer compositions and methods | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2021-04-20 | — | — | US | claimed |
| US-20200339732-A1 | RIGID FOAMS | ECONIC TECHNOLOGIES LTD (GB) | 2020-10-29 | — | — | US | claimed |
| EP-3728367-A1 | RIGID FOAMS | Econic Technologies Limited (GB) | 2020-10-28 | — | — | EP | claimed |
| US-20200087436-A1 | POLYMER COMPOSITIONS AND METHODS | NOVOMER, INC. | 2020-03-19 | — | — | US | claimed |
| US-10351654-B2 | Polymer compositions and methods | SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) | 2019-07-16 | — | — | US | claimed |
| US-20180334525-A1 | POLYMER COMPOSITIONS AND METHODS | NOVOMER, INC. | 2018-11-22 | — | — | US | claimed |
| EP-2177552-B1 | Bioabsorbable surgical composition | COVIDIEN LP (US) | 2013-03-27 | — | — | EP | claimed |
| US-20110015672-A1 | Method for Coating a Medical Device | TYCO HEALTHCARE GROUP LP | 2011-01-20 | — | — | US | claimed |
| EP-2275150-A2 | Method for coating a medical device | Tyco Healthcare Group, LP (US) | 2011-01-19 | — | — | EP | claimed |
| EP-2177552-A1 | Bioabsorbable surgical composition | Tyco Healthcare Group LP (US) | 2010-04-21 | — | — | EP | claimed |
| US-20100092533-A1 | Bioabsorbable Surgical Composition | COVIDIEN LP | 2010-04-15 | — | — | US | claimed |
| US-20090266467-A1 | Bioabsorbable Surgical Composition | TYCO HEALTHCARE GROUP LP | 2009-10-29 | — | — | US | claimed |
| JP-2009518522-A | — | — | 2009-05-07 | — | — | JP | claimed |
| EP-1966311-A2 | VISCOSITY-REDUCED SPRAYABLE COMPOSITIONS | Tyco Healthcare Group, LP (US) | 2008-09-10 | — | — | EP | claimed |
| WO-2007067761-A2 | VISCOSITY-REDUCED SPRAYABLE COMPOSITIONS | TYCO HEALTHCARE GROUP LP (US) | 2007-06-14 | — | — | WO | claimed |
| US-20070135566-A1 | Viscosity-reduced sprayable compositions | TYCO HEALTHCARE GROUP LP | 2007-06-14 | — | — | US | claimed |
| US-20250263516-A1 | RIGID FOAMS | ECONIC TECHNOLOGIES LTD. (GB) | 2025-08-21 | — | — | US | disclosed |
| US-4883826-A | Tertiary amine-containing polyols prepared in a mannich condensation reaction using a mixture of alkanolamines | THE DOW CHEMICAL COMPANY (US) | 1989-11-28 | — | — | US | disclosed |
| US-4704410-A | QUICK-SETTING, GOOD FLOWABILITY, COMPRESSIVE STRENGTH | THE DOW CHEMICAL COMPANY (US) | 1987-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100092533-A1 | Bioabsorbable Surgical Composition | CD44, EPCAM, CD68 | HTR2A 1219/4885HRH1 2032/4885ALDH1A1 1879/4885 |
| US-20090266467-A1 | Bioabsorbable Surgical Composition | EPCAM, FABP2, CD68 | HTR2A 2504/4885HRH1 3339/4885ALDH1A1 2231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.